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Background: Bovine rotavirus (BRV) is a non-enveloped dsRNA virus that cause neonatal calf diarrhea. Lipid rafts
are cholesterol-enrich membrane mircodomains that play a vital role in many cellular processes. In this study, the
effect of cellular cholesterol depletion on infection of MA-104 cells with bovine rotavirus was investigated.
Results: We demonstrated that cholesterol depletion of the plasma membrane by MβCD had no effect on BRV
binding to cells but significantly impaired BRV entry in a dose-dependent manner and the effect was partially
reversed by addition of exogenous cholesterol, suggesting the reduction of BRV infection by MβCD was specifically
due to cholesterol depletion. Cholesterol depletion after virus entry did not reduce BRV replication, whereas affected
virus assembly.
Conclusions: Taken together, our results demonstrate that cell membrane cholesterol is essential to BRV infectivity.
Keywords: Bovine rotavirus, Cholesterol, Methyl-β-cyclodextrin, InfectionBackground
Bovine Group A rotavirus (BRV), a member of the
Reoviridae family, is recognized as a major agent of neo-
natal calf diarrhea that causes severe diarrhoea, dehy-
dration, anorexia and death in newborn calves [1].
Rotavirus is a non-enveloped double-stranded RNA virus
that consists of 6 structural (VP1-VP4, VP6 and VP7) and
5 or 6 nonstructural proteins (NSP1-6) [2,3]. Rotaviruses
are classified into G and P genotypes based on the genetic
variation of VP7 (Glycoprotein) and VP4 (Protease sen-
sitive protein) outer capsid proteins, respectively [4]. To
date, 27 G and 37 P types have been recognized. The G6,
G8 and G10 in combination with the P (1), P (5) and P
(11) genotypes are prevalent in cattle among the world
[4-7]. A recent study revealed that some BRV strains could
transmit directly to human infants and cause diarrhea [8].
The emergence of novel strains and the risks of interspe-
cies transmission are of great concern.
Lipid rafts are specialized membrane microdomains
that are enriched in sphingolipids, cholesterol, SRC
family protein kinases, and glycosylphosphatidylinositol
(GPI)-anchored proteins, cholesterol is essential in lipid* Correspondence: shoujunli@scau.edu.cn
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unless otherwise stated.raft membranes [9,10]. Lipid rafts are associated with
regulation of various physiological processes, such as lipid
sorting, protein trafficking [11], cell polarization and sig-
nal transduction [12]. For virus, cholesterol-enrich mem-
brane mircodomains play an important role in multiple
stages of virus life cycle, including entry, fusion, repli-
cation, assembly and budding [13-15]. Numerous studies
have demonstrated that the cellular cholesterol was re-
quired for infection of many viruses, such as PRRSV [16],
TGEV [17], bovine herpesvirus type 1 (BoHV-1) [18],
murine leukemia virus [19] and simian virus 40 (SV40)
[20], whereas influenza virus infection is independent of
cell cholesterol [21]. Previous studies have found that lipid
membrane microdomains are indispensable to the infec-
tion of simian, porcine and human rotaviruses [22-25]. In
addition, bovine rotavirus UK strain seem to enter the cell
through clathrin-mediated endocytosis [26]. However,
whether cellular cholesterol impact other stages of BRV
life cycle remains unclear.
In this study we explored whether cellular cholesterol
depletion affects BRV infection, furthermore, the stage of
BRV infection cycle which depends on cell cholesterol has
also been determined. Using Methyl-β-cyclodextrin
(MβCD), a pharmacological cholesterol depletion agent,
we found that cellular cholesterol affected BRV entry but
not virus binding, and the inhibitory effect was partially. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cell membrane cholesterol was dispensable for the virus
replication. However, virus assembly was in a cholesterol-
dependent pathway. These results suggested that cellular
cholesterol is required for BRV infection.
Results
Cholesterol depletion had no effect on BRV binding
In order to disrupt the lipid rafts, the cholesterol in cel-
lular membranes was extracted by MβCD. MA-104 cells
were treated with different concentrations of MβCD
(0, 2.5, 5, 10 and 15 mM) for 30 min, then the cytoto-
xicity was measured by CCK-8 assay, the results showed
that the cell survival rate (Figure 1A) did not differ sig-
nificantly between treated and mock treated cells. The
cholesterol contents of cellular membranes were mea-
sured by the Amplex Red cholesterol assay kit. Total cel-
lular cholesterol levels of MβCD-treated MA-104 cells
were decreased in a dose-dependent manner. As shown
in Figure 1B, the amount of cholesterol following treat-
ment with 2.5, 5, 10 or 15 mM MβCD was reduced by
15.4%, 24.9%, 60.7% or 70.7% compared with untreated
cells, respectively.
To test whether cholesterol depletion was able to
inhibit virus attachment, virus binding assay was per-
formed. MA-104 cells were pretreated with MβCD for
30 min, and then incubated with virus at 4°C for 1 h,
virus can merely absorb to cells under this temperature.
As shown in Figure 1C, no inhibitory effect was detected
by virus titration assay. It indicated that cholesterol de-
pletion had no effect on BRV attachment.Figure 1 Cellular cholesterol is not required for BRV attachment. (A) C
30 min was determined with CCK-8 Kit. (B) The cellular cholesterol levels w
depletion had no effect on BRV attachment. Cells were mock treated or tre
with BRV at 4°C. At 1 h later, cell lysates were prepared by freeze-thaw andCholesterol depletion impaired BRV entry into MA-104
cells
To determine the effect of cholesterol depletion on BRV
entry, MA-104 cells were pretreated with various con-
centrations of MβCD, followed by BRV incubation. The
virus production was determined at 12 hpi. The virus
titers (Figure 2A) and viral mRNA levels (Figure 2B)
were decreased in a dose-dependent manner. At a con-
centration of 15 mM, 3.22 log10 reduction in virus titer
and 99.81% reduction of viral mRNA compared to mock
treated cells were observed.
To study at which time point cellular cholesterol be-
came dispensable for infection, cells were exposed to
MβCD during or after virus entry, as shown in Figure 2C,
infection was inhibited when cells were treated during
entry stage (up to 0.5 h postinternalization, Lane 2 and 3)
compared to nontreated cells. However, cholesterol deple-
tion after viral entry (1 h, 2 h, 4 h and 6 h postinternaliza-
tion, lane 4 to 7) had no effect on viral protein expression.
These results indicated that depletion of cellular choles-
terol by MβCD impairs BRV entry into MA-104 cells.
The inhibitive effect was partially reversed by cholesterol
replenishment
To confirm the impairment of BRV entry by MβCD was
due to depletion of cell cholesterol and whether the effect
was reversible, MA-104 cells were pretreated with 10 mM
MβCD for 30 min, and then suppled with 1.5 mg/ml
exogenous cholesterol for 1 h, followed by BRV infection
and determination of virus yield. As expected, the con-
tent of cellular cholesterol was restored to about 79.4%ell viability after treatment with various concentrations of MβCD for
ere measured by Amplex Red cholesterol assay kit. (C) Cholesterol
ated with indicated concentrations of MβCD for 30 min, then infected
virus titers were measured.
Figure 2 Cholesterol depletion reduced BRV entry. MA-104 cells were pretreated with different concentrations of MβCD followed by BRV
infection for 12 h. (A) The virus titers were determined by TCID50 assay. (B) Viral mRNA levels were measured by Realtime PCR, results are expressed as
the fold increase relative to mock-treated control (set at 1.0). All experiments were performed three times, and the error bars indicated the standard
deviations of three independent experiments. (C) After virus attachment, the unbound BRV was removed, cells were treated with MβCD at indicated
time at 37°C. At 12 hpi, the levels of VP4 in the BRV-infected cells were detected by Western blotting.
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titers increased by 2.0 log10 (Figure 3B). These results
demonstrated that the reduction of virus production by
MβCD acts through depletion of cellular cholesterol and
this effect was partially reversible.
Effect of cellular cholesterol depletion on post-entry
process
In order to analyze the effect of cellular cholesterol on
post-entry stage of BRV infection, MA-104 cells were pre-
incubated with BRV for 1 h at 37°C to ensure that virus
has already entered into cells, and then treated with
various concentrations of MβCD at 37°C for 30 min.Figure 3 The infection ability of BRV was partially recovered with the
pretreated with 10 mM MβCD for 30 min, and then supplied with 1.5 mg/ml
cellular cholesterol was determined with Amplex Red cholesterol assay kit. (B
performed in triplicate. “***” denotes extremely significant difference in statistCompared to untreated cells, viral mRNA levels (Figure 4A)
and protein amounts (Figure 2C) of treated cells were not
reduced, however, virus titers were significantly decreased
(Figure 4B). These data shown that BRV replication on
MA-104 cells is independent of cell cholesterol and cho-
lesterol depletion impaired virus assembly.
Discussion
Rotaviruses are the major cause of severe acute dehy-
drating diarrhea in humans and animals worldwide [2].
In vitro, African green monkey kidney cell (MA104) is
the most commonly used cell in rotavirus propagation.
Rotavirus entry is an organized multistep process, it hasreplenishment of exogenous cholesterol. MA-104 cells were
exogenous cholesterol for 1 h followed BRV infection. (A) Content of
) 12 h post infection, virus titers were determined. Each experiment was
ics (P < 0.001).
Figure 4 Cholesterol depletion after virus entry did not affect BRV replication but virus assembly. MA-104 cells were incubated with BRV
for 1 h, then treated with various concentrations of MβCD, (A) viral mRNA levels (B) and virus titers were determined at 12 hpi. The results were
representative of three independent experiments.
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direct penetration or by receptor-mediated endocytosis
[27,28]. N-acetylneuraminic (sialic) acid residues, integrins
α2β1, α4β1, αvβ3, αxβ2, heat shock cognate protein (hsc)
70 and certain gangliosides were identified as cellular mo-
lecules which were responsible for rotavirus entry [29,30].
Previous research indicated that cellular cholesterol is
required for infection of some rotavirus species [22-25].
Meanwhile, cholesterol depletion impairs the entry of
BRV UK strain [26]. However, BRV strains have various
VP4 (P-types) and VP7 (G-types) genotypes and they were
clustered into different lineages [31]. In addition, whether
cholesterol affects BRV attachment or after-entry stage
have not been reported. In this study, the critical role of
cellular cholesterol on specific phase of BRV CH-12 strain
was investigated, we found that the cellular cholesterol is
sensitive to MβCD treatment. With the treatment of in-
creasing concentrations of MβCD the cholesterol content
of plasma membrane was decreased in a dose-dependent
manner, and replenishing cellular membrane with exo-
genous cholesterol partially restored the cholesterol level.
In order to determine which stage of BRV life cycle is
affected by cholesterol depletion, we first examined the
effect of cellular cholesterol depletion on virus binding,
the results showed that BRV attachment was independent
to cholesterol. However, when cells were treated with
MβCD prior to virus entry, BRV infection was decreased
with the reduction of cellular cholesterol level in a dose-
dependent fashion. The replenishing of exogenous choles-
terol enhanced the infectivity of BRV. To investigate
whether cholesterol depletion affects virus entry or repli-
cation, cells were treated with MβCD after BRV entry, the
result revealed that there were no significant differences of
viral mRNA and protein levels between treated cells and
mock cells. These results indicated that cholesterol deple-
tion from cellular membrane did not affect the replication
of BRV but virus entry. As reported, lipid raft is involved
in several viruses entry into cells, such as PRRSV [16],BoHV-1 [18], human enterovirus [32], poliovirus [33] and
canine distemper virus [34], cellular receptors of several vi-
ruses are localized in the lipid rafts. Although diverse rota-
viruse species interact with different cell-surface molecules,
some of these molecules are localized in the lipid rafts [30].
Hence, cholesterol depletion from cellular membrane in-
fluences BRV entry by disturbing lipid-raft-dependent
endocytosis. Our results showed that cholesterol depletion
had no effect on BRV replication, suggesting that virus rep-
lication is independent of lipid rafts, and it is in accordance
with the former reports for other viruses [16,18].
Previous study demonstrated that Lovastatin-treated
cells increased the levels of simian rotavirus proteins [35].
In the present work, we found that the synthesis of viral
mRNA and protein were not affected when cells were
treated with MβCD after virus entry, but the virus titers
were obviously decreased, it appears that cholesterol-rich
microdomains may contribute to assembly or budding of
BRV. Lipids membrane microdomains play an important
role in numerous cellular functions such as signal trans-
duction, membrane transport and trafficking [36] and pro-
vide platforms for assembly or budding of many enveloped
viruses such as influenza virus [37], HIV [38] and morbilli-
virus measles virus [39]. The mechanism of noneveloped
viruses assembly and release is still poorly understood.
The release of some noneveloped viruses from cells does
not involve cell lysis. Virions transported to specific
plasma membrane domains through vesicular transport,
inhibition of the accumulation of virus on cell surfaces did
not affect viral RNA and protein synthesis but block virus
release [40,41]. Recently, compounds that could inhibit
rotavirus viroplasm formation and decrease the amount of
infectious progeny by disrupting lipid droplets (LDs) or
fatty acid synthesis were reported [42,43]. In Caco-2 Cells,
rotavirus VP4 protein has been demonstrated to directly
interact with lipid microdomains. At the final stage of
assembly, VP4 incorporates into preformed viral particles,
lipid rafts provide a platform for the formation of
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disrupted by MβCD impaired the mature of BRV particles
and decreased the virus titers.
In conclusion, our results suggested that lipid rafts
play a vital role in BRV infection and plasma membrane
cholesterol was essential to BRV entry and assembly.
Materials and methods
Cells, viruses and chemicals
MA-104 African green monkey cells were maintained in
DMEM containing 10% fetal bovine serum, and 1% peni-
cillin/streptomycin. The BRV strain CH12 (kindly provi-
ded by Dr. Kun Jia, South China Agricultural University)
was propagated in MA-104 cells in the presence of trypsin
(final concentration was 5 mg/mL) at a multiplicity of in-
fection (MOI) of 0.1. Methyl-β-cyclodextrin (MβCD) and
cholesterol were purchased from Sigma-Aldrich (Sigma-
Aldrich, St. Louis, MO, USA). The reagents were dissolved
in water and diluted in serum-free DMEM.
Depletion and replenishment of cholesterol
In order to deplete cholesterol, the cells were treated
with increasing concentrations of MβCD (0, 2.5, 5, 10
and 15 mM) at 37°C for 30 min. For cholesterol reple-
nishment, MA-104 cells were pretreated with 10 mM
MβCD at 37°C for 30 min, after washing, the cells were
incubated with 1.5 mg/ml exogenous cholesterol for 1 h
at 37°C.
Toxicity of MβCD and cholesterol quantification
The cell viability was measured by Cell Counting Kit
(CCK-8) (Dojindo, Japan) following the manufacturer’s
instructions. Briefly, MA-104 cells cultured in 96-well
plates were treated without or with various concentra-
tions of MβCD at 37°C for 30 min. Subsequently, 10 μl
of the CCK-8 solution was added to each well and incu-
bated at 37°C for 1 h, the optical density (OD) value of
the wells at a wavelength of 450 nm was measured using
a microplate reader (Bio-Rad, USA). Relative cell viabil-
ity rate was determined for each concentration as [(OD
experiment - OD blank)/(OD control - OD blank) ×
100], all experiments were repeated three independent
times.
To determine the cellular cholesterol level, the choles-
terol-depleted or cholesterol-replenished cells were col-
lected and diluted in 1X Amplex Red Reaction Buffer. The
concentration of cholesterol was detected by the Amplex
Red cholesterol Assay Kit (Life Technologies, USA) ac-
cording to the manufacturer’s instructions.
Effect of cholesterol depletion on virus binding
In order to examine if cholesterol depletion affects BRV
binding to MA-104 cells, the monolayer cells seeded in
12-well plates were incubated with indicated concentrationsof MβCD at 37°C for 30 min, and then infected with BRV
at a multiplicity of infection (MOI) of 0.1 at 4°C for 1 h.
After removing the unbound virus with PBS, cell lysates
were prepared by freeze-thaw three times and virus titers
were determined.
Effect of cholesterol depletion on the BRV entry
To determine the effect of cellular cholesterol depletion
on virus entry, the monolayer MA-104 cells cultured in
12-well plates were mock treated or treated with various
concentrations of MβCD at 37°C for 30 min, then incu-
bated with BRV at a MOI of 0.1 at 37°C. One hour later,
cells were washed three times with PBS and supplied
with serum-free medium, virus titers and viral mRNA
levels were quantified at 12 hours post infection.
For cholesterol replenishment assay, the MA-104 cells
were pretreated with 10 mM MβCD for 30 min, then in-
cubated with cholesterol at a concentration of 1.5 mg/ml
for 1 h. After washing, the cells were infected with BRV.
At 12 hpi, virus titers were calculated.
Add-in assay
Cells were infected with BRV at 4°C for 1 h. After bin-
ding, cells were washed with PBS to remove unbound
virus, then shifted to 37°C (set as 0 h) to allow virus in-
ternalization. 30 mM MβCD was added at 0, 0.5, 1, 2, 4
and 6 h. At 12 h post infection, cells were harvested and
subjected to Western blot assay.
Effect of cholesterol depletion on post-entry stage of BRV
infection
In order to analyze whether cholesterol depletion could
affect virus infectivity after virus entry, MA-104 cells
seeded in 12-well plates were infected with BRV for 1 h
at 37°C, then mock treated or treated with various con-
centrations of MβCD at 37°C for 30 min. After washing,
cells were kept in serum-free medium for 12 h, the virus
titers and mRNA levels were determined.
Virus titration
The monolayer MA104 cells seeded in 96-well plates
were infected with serially 10-fold diluted virus. After
48 h, the level of virus infection was determined by cyto-
pathic effect (CPE), virus titers were calculated by the
Reed and Muench method and expressed as 50% tissue
culture infective dose (TCID50) per ml.
Realtime PCR
Total RNA was isolated using TRIzol reagent (Life
Technologies, USA) and treated with RNA-free DNase
(Roche) to eliminate possible DNA contamination. Re-
verse transcription was carried out by using Revert Aid
First Strand cDNA Synthesis Kit (Thermo Scientific). The
Realtime PCR was done with the SYBR Select Master Mix
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instructions. The primer set designed for BRV VP7 gene
contains BRV-VP7-F (5′-TAA ATG GAT ATC AAT GGG
TT-3′) and BRV-VP7-R (5′-AAC GTC AGT AAT TAC
CAG C-3′), and the primer set designed for β-actin gene
contains β-actin-F (5′-TCG ATC ATG AAG TGC GA
CGT G-3′) and β-actin-R (5′-GTG ATC TCC TTC TGC
ATC CTG TC-3′). The PCR reaction was performed with
ABI7500 Fast Realtime PCR (Applied Biosystems, USA).
Relative levels of viral mRNA were calculated using the
2-ΔΔCT method of relative quantification with β-actin as
the internal control for normalization.
Western blot
Cells were harvested in Laemmli sample buffer and sub-
jected to SDS-PAGE, then transferred to a nitrocellulose
membrane (Millipore). The membrane was blocked with
5% nonfat dry milk in TBS and incubated with the poly-
clonal antibody against BRV VP4 protein, anti-rabbit IgG
(H + L) (DyLight 800 Conjugate) was used as secon-
daryantibody (Cell Signaling). The blots were developed
using LI-COR Odyssey System (LI-COR).
Statistical analysis
The data were presented as mean ± standard deviations
(SD) of three independent experiments. The differences
between groups were assessed by Student’s t test. A
P value < 0.05 was considered statistical significant. All
statistical analyses were performed using GraphPad Prism.
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